Genotypic analysis of thiopurine S-methyltransferase in patients with Crohn's disease and severe myelosuppression during azathioprine therapy

This publication has 28 references indexed in Scilit:

• Genotypic and phenotypic analysis of the polymorphic thiopurine S‐methyltransferase gene (TPMT) in a European population
  British Journal of Pharmacology, 1998
• Human thiopurine methyltransferase pharmacogenetics. Kindred with a terminal exon splice junction mutation that results in loss of activity.
  Journal of Clinical Investigation, 1998
• Detection of known and new mutations in the thiopurineS-methyltransferase gene by single-strand conformation polymorphism analysis
  Human Mutation, 1998
• Human thiopurine methyltransferase pharmacogenetics: Gene sequence polymorphisms*
  Clinical Pharmacology & Therapeutics, 1997
• Molecular Diagnosis of Thiopurine S-Methyltransferase Deficiency: Genetic Basis for Azathioprine and Mercaptopurine Intolerance
  Annals of Internal Medicine, 1997
• Thiopurine Methyltransferase Pharmacogenetics: Human Gene Cloning and Characterization of a Common Polymorphism
  DNA and Cell Biology, 1996
• A single point mutation leading to loss of catalytic activity in human thiopurine S-methyltransferase.
  Proceedings of the National Academy of Sciences, 1995
• Bone marrow toxicity caused by azathioprine in inflammatory bowel disease: 27 years of experience.
  Gut, 1993
• Genetic variation in response to 6-mercaptopurine for childhood acute lymphoblastic leukaemia
  The Lancet, 1990
• Thiopurine pharmacogenetics in leukemia: Correlation of erythrocyte thiopurine methyltransferase activity and 6-thioguanine nucleotide concentrations
  Clinical Pharmacology & Therapeutics, 1987